The Economic Burden of ACPA-Positive Status Among Patients with Rheumatoid Arthritis

por Shafrin, Jason, Tebeka, Mahlet Gizaw, Price, Kwanza, Patel, Chad, Michaud, Kaleb
Publicado 2018

Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada

por Weijers, Laure, Baerwald, Christoph, Mennini, Francesco S., Rodríguez-Heredia, José M., Bergman, Martin J., Choquette, Denis, Herrmann, Kirsten H., Attinà, Giulia, Nappi, Carmela, Merino, Silvia Jimenez, Patel, Chad, Mtibaa, Mondher, Foo, Jason
Publicado 2017